Effect of FAST HUGS WITH ICU Approach on Length of Intensive Care Unit Stay in Patients With Hypoxic Respiratory Failure
Condition(s) studied
Investigational drug(s) / intervention(s)
FAST HUGS WITH ICU approach: FAST HUGS WITH ICU; It is an abbreviation of "Feeding, Analgesia, Sedation, Thromboembolic prophylaxis, Head of bed elevation, Stress Ulcer prophylaxis and Glucose control Spontaneous breathing trial, Water Balance and constipation, Investigation and results, Therapy, Hypo-hyper delirium, Invasive devices, Check the daily infection parameters, Use a checlist". With this approach, patients will be followed up.
Study summary
This study will investigate the effect of the FAST HUGS WITH ICU approach on the length of stay in the intensive care unit in patients with hypoxic respiratory failure. Patients will be randomly assigned to the experimental and control groups. The standard procedure will be applied to the control group. The FAST HUGS WITH ICU approach will be applied to the experimental group. We plan to follow up patients with Hypoxic Respiratory Failure using the abbreviation FAST HUGS WITH ICU (Feeding, Analgesia, Sedation, Thromboembolic prophylaxis, Head of bed elevation, Stress Ulcer prophylaxis and Glucose control Spontaneous breathing trial, Water Balance and constipation, Investigation and results, Therapy, Hypo-hyper delirium, Invasive devices, Check the daily infection parameters, Use a checlist). The two groups will be examined in terms of hospital stay and some blood gas parameters.
Eligibility
Primary outcome measure(s)
- length of hospital stay — 1 month
The difference between the duration of participants' admission to the intensive care unit and the time they are discharged from the intensive care unit will be examined.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ataturk University Research Hospital | Erzurum | Turkey (Türkiye) | Recruiting |
More Muş Alparslan University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06901050 on ClinicalTrials.gov ↗ ← All trials in Turkey